2-Amino-4-chlorothiazole-5-carbaldehyde

Catalog No. :
ACEAZI268
CAS No. :
76874-79-8
Molecular Formula :
C4H3ClN2OS
Molecular Weight :
162.60

IUPAC Name:2-amino-4-chlorothiazole-5-carbaldehyde

2-Amino-4-chlorothiazole-5-carbaldehyde structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g95%$71.00Login to see priceIn stockInquiry
10g95%$112.00Login to see priceIn stockIn stock
25g95%$224.00Login to see priceIn stockIn stock
100g95%$670.00Login to see priceIn stockInquiry
500g95%$3250.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Amino-4-chlorothiazole-5-carbaldehyde
IUPAC Name2-amino-4-chlorothiazole-5-carbaldehyde
MDL No.MFCD00204993
Molecular FormulaC4H3ClN2OS
Molecular Weight162.60
SMILESNC1=NC(=C(S1)C=O)Cl
InChI KeyKJRBYUWRYRRPKN-UHFFFAOYSA-N
Synonym2-Amino-4-chlorothiazole-5-carbaldehyde | 76874-79-8 | 2-Amino-4-chloro-5-formylthiazole | 2-amino-4-chloro-1,3-thiazole-5-carbaldehyde | 2-AMINO-4-CHLORO-5-THIAZOLECARBALDEHYDE | MFCD00204993 | 2-Amino-4-chloro-5-formyl-1,3-thiazole | C4H3ClN2OS | 5-Thiazolecarboxaldehy
CAS No.76874-79-8
PubChem CID11030154

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H332-H335
Precautionary Statement(s)
P261-P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACEAZI268 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACXCSI780 route compound structure diagram
    ACXCSI78052107-46-7 In Stock
  4. Then
  5. ACEAZI268 route product structure diagram
    ACEAZI26876874-79-8 In Stock
Inquiry

2. ACEAZI268 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACEAZI268 route product structure diagram
    ACEAZI26876874-79-8 In Stock
Inquiry

Comments (0)